These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 28516940)
21. US lawyers investigate trial that secured license for AstraZeneca's antiplatelet drug. Cohen D BMJ; 2013 Nov; 347():f6727. PubMed ID: 24212110 [No Abstract] [Full Text] [Related]
22. No sisyphean task: how the FDA can regulate electronic cigarettes. Paradise J Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824 [TBL] [Abstract][Full Text] [Related]
24. Congress examines childhood vaccine safety. Dove A Nat Med; 1999 Sep; 5(9):970. PubMed ID: 10471261 [No Abstract] [Full Text] [Related]
25. The federal preemption debate in pharmaceutical labeling product liability actions. Gross JM; Curry JA Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866 [No Abstract] [Full Text] [Related]
26. Disclosure of cigarette ingredients: potential domino effect? Buasai S Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):613-4. PubMed ID: 7667700 [No Abstract] [Full Text] [Related]
27. Safety dominates the debate on electronic cigarettes. The Lancet Respiratory Medicine Lancet Respir Med; 2014 Jun; 2(6):429. PubMed ID: 24853584 [No Abstract] [Full Text] [Related]
28. The FDA, preemption, and public safety. Gostin LO Hastings Cent Rep; 2011; 41(5):11-2. PubMed ID: 21980892 [No Abstract] [Full Text] [Related]
29. They are from the government and they really are here to help you. Woosley RL J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889 [No Abstract] [Full Text] [Related]
30. Steve Carney talks to Vincent Lee on the pharma industry, the FDA and public education with respect to drugs and their development. Lee VH Drug Discov Today; 2005 Nov; 10(21):1411-4. PubMed ID: 16243258 [No Abstract] [Full Text] [Related]
31. US 21st Century Cures Act secures health-care research funding. Furlow B Lancet Oncol; 2017 Jan; 18(1):24. PubMed ID: 27979600 [No Abstract] [Full Text] [Related]
32. Assessment of US pathway for approving medical devices for rare conditions. Hwang TJ; Carpenter D; Kesselheim AS BMJ; 2014 Jan; 348():g217. PubMed ID: 24443478 [No Abstract] [Full Text] [Related]
33. The FDA defense: a prescription for easing the pain of punitive damage awards in medical products liability cases. Marthaler AL Spec Law Dig Health Care Law; 1997 Sep; (223):9-45. PubMed ID: 10173273 [No Abstract] [Full Text] [Related]
34. Finally the US regulates e-cigarettes as tobacco. Kamerow D BMJ; 2016 May; 353():i2596. PubMed ID: 27154900 [No Abstract] [Full Text] [Related]
35. The little agency that could (act with indifference to constitutional and statutory strictures). Noah L Cornell Law Rev; 2008 Jul; 93(5):901-26. PubMed ID: 18618963 [No Abstract] [Full Text] [Related]
36. The impact of FDA reform. Trunzo J Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699 [TBL] [Abstract][Full Text] [Related]
37. US is to regulate all tobacco products, including e-cigarettes and hookah tobacco. McCarthy M BMJ; 2016 May; 353():i2594. PubMed ID: 27154555 [No Abstract] [Full Text] [Related]
38. Policy reform: Strengthen and stabilize the FDA. Carpenter D Nature; 2012 May; 485(7397):169-70. PubMed ID: 22575942 [No Abstract] [Full Text] [Related]
39. A turbulent year at the agency. Ratner M Nat Biotechnol; 2006 Feb; 24(2):145-51. PubMed ID: 16465153 [No Abstract] [Full Text] [Related]
40. Treading Lightly: Why The FDA Should Use Its New Authority To Regulate Electronic Cigarettes Sparingly. Ray AP J Leg Med; 2015; 36(2):215-31. PubMed ID: 27128338 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]